![James Meyers](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
James Meyers
Director/Board Member at
CYTOMX THERAPEUTICS, INC.
Net worth: 12 309 $ as of 2026-08-30
Profile
Mr. James R.
Meyers is an Independent Director at Vera Therapeutics, Inc., a Chairman at IntegriChain, Inc., an Independent Director at Sangamo Therapeutics, Inc. and an Independent Director at CytomX Therapeutics, Inc. He is on the Board of Directors at Vera Therapeutics, Inc., Sangamo Therapeutics, Inc., CytomX Therapeutics, Inc., Biotechnology Innovation Organization, California Biomedical Innovation Alliance and Pulmocide Ltd. Mr. Meyers was previously employed as a President & Chief Executive Officer by IntraBio, Inc., an Independent Director by Arbutus Biopharma Corp., and an Executive VP-Worldwide Commercial Operations by Gilead Sciences, Inc. He received his undergraduate degree from Boston College.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-04-19 | 74,600 ( 0.02% ) | 12 309 $ | 2026-08-30 | |
| 2026-06-16 | 0 ( -.--% ) | - $ | 2026-08-30 | |
| 2026-05-20 | 0 ( -.--% ) | - $ | 2026-08-30 |
James Meyers active positions
| Companies | Position | Start |
|---|---|---|
| CYTOMX THERAPEUTICS, INC. | Director/Board Member | 2018-12-19 |
| SANGAMO THERAPEUTICS, INC. | Director/Board Member | 2019-11-21 |
| VERA THERAPEUTICS, INC. | Director/Board Member | 2025-11-24 |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Director/Board Member | - |
California Biomedical Innovation Alliance
 California Biomedical Innovation Alliance BiotechnologyHealth Technology Provides biomedical advocacy and community services | Director/Board Member | - |
Pulmocide Ltd.
 Pulmocide Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops inhaled medicines for viral and fungal infections of the respiratory diseases | Director/Board Member | - |
IntegriChain, Inc.
 IntegriChain, Inc. Packaged SoftwareTechnology Services Develops data-driven commercialization platform for pharma manufacturers | Chairman | 2024-02-29 |
Former positions of James Meyers
| Companies | Position | End |
|---|---|---|
| ARBUTUS BIOPHARMA CORPORATION | Director/Board Member | 2025-02-23 |
IntraBio, Inc.
 IntraBio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel drugs | Chief Executive Officer | 2023-12-31 |
| ░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Training of James Meyers
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
86
1st degree connections
11
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 11 |
|---|---|
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Sangamo Therapeutics, Inc.
 Sangamo Therapeutics, Inc. BiotechnologyHealth Technology Operates as a genomic medicine company | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Arbutus Biopharma Corp.
 Arbutus Biopharma Corp. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics which targets viral diseases | Health Technology |
Boston College
 Boston College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
IntegriChain, Inc.
IntegriChain, Inc. Packaged SoftwareTechnology Services Develops data-driven commercialization platform for pharma manufacturers | Technology Services |
Pulmocide Ltd.
Pulmocide Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops inhaled medicines for viral and fungal infections of the respiratory diseases | Health Technology |
CytomX Therapeutics, Inc.
 CytomX Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an oncology-base biopharmaceutical company, which focuses on developing probody therapeutics for the treatment of cancer | Health Technology |
California Biomedical Innovation Alliance
California Biomedical Innovation Alliance BiotechnologyHealth Technology Provides biomedical advocacy and community services | Health Technology |
IntraBio, Inc.
IntraBio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel drugs | Health Technology |
Vera Therapeutics, Inc.
 Vera Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company, which focuses on development and treatments for immunological & inflammatory diseases | Health Technology |
- Stock Market
- Insiders
- James Meyers
